Dec 21 (Reuters) - Barinthus Biotherapeutics PLC
2ABy.F :
* BARINTHUS BIOTHERAPEUTICS PLC: NEW PARTNERSHIP AIMS TO
ADVANCE
VACCINE AGAINST MERS CORONAVIRUS
* BARINTHUS BIOTHERAPEUTICS PLC: COALITION FOR EPIDEMIC
PREPAREDNESS INNOVATIONS TO INVEST FUNDING OF UP TO $34.8
MILLION TO BARINTHUS BIO
* BARINTHUS BIOTHERAPEUTICS:PARTNERSHIP AIMS TO FAST-TRACK
DEVELOPMENT OF VACCINE CANDIDATE, VTP-500, FOR PREVENTION OF
MIDDLE EAST RESPIRATORY SYNDROME
* BARINTHUS BIOTHERAPEUTICS PLC-VACCINE WILL BE MADE
AVAILABLE TO
LOW-, MIDDLE-INCOME COUNTRIES AT PRICE NO HIGHER THAN COST OF
MANUFACTURING PLUS 10%
Source text for Eikon: ID:nGNX376mtQ
Further company coverage: 2ABy.F
((Reuters.Briefs@thomsonreuters.com;))